Kyverna Therapeutics, Inc. (KYTX) Presents at Leerink Global Healthcare Conference 2026 Transcript [Seeking Alpha]
Kyverna Therapeutics, Inc. (KYTX)
Company Research
Source: Seeking Alpha
Warner Biddle - CEO & Director Conference Call Participants Thomas Smith - Leerink Partners LLC, Research Division Presentation Thomas Smith Leerink Partners LLC, Research Division Go ahead and get started. Good morning, everyone. Thanks for joining us here at the Leerink Partners Global Healthcare Conference. My name is Tom Smith. I'm one of the senior biotech analysts here at Leerink. It's my pleasure to welcome our next company to the stage, Kyverna Therapeutics, represented by CEO, Warner Be. Warner, thanks for joining us. Warner Biddle CEO & Director Thanks. It's great to be here, Tom. Thank you. Question-and-Answer Session Thomas Smith Leerink Partners LLC, Research Division Awesome. And I just want to -- I mean, Kyverna made huge progress in 2025. You reported positive top line results from your pivotal study for your autologous CD19 CAR-T therapy, miv-cel in Stiff-Person syndrome. And we're entering a really exciting period, potentially transformativ
Show less
Read more
Impact Snapshot
Event Time:
KYTX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
KYTX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
KYTX alerts
High impacting Kyverna Therapeutics, Inc. news events
Weekly update
A roundup of the hottest topics
KYTX
News
- Kyverna Therapeutics to Present New Data from Neuroimmunology Franchise at AAN 2026 [Yahoo! Finance]Yahoo! Finance
- Kyverna Therapeutics to Present New Data from Neuroimmunology Franchise at AAN 2026GlobeNewswire
- Kyverna Therapeutics to Participate in Upcoming March Investor ConferencesGlobeNewswire
- Kyverna Therapeutics (KYTX) was upgraded by <a style="font-weight:bold" href="https://www.wallstreetzen.com/newsletters/zen-ratings?ticker=KYTX&utm_campaign=getratings&utm_medium=online&utm_source=MarketBeat">Wall Street Zen</a> from "selMarketBeat
- Kyverna Therapeutics Appoints Biotech Leaders Sravan Emany and Andrew Miller to Board of DirectorsGlobeNewswire
KYTX
Earnings
- 11/12/25 - Beat
KYTX
Sec Filings
- 3/4/26 - Form 4
- 3/4/26 - Form 3
- 2/26/26 - Form 3
- KYTX's page on the SEC website